Daniel Grint
@DanielJGrint
Followers
23
Following
7
Media
0
Statuses
6
Statistician @LSHTM / @ISEG_LSHTM | TB and HIV treatment clinical trialist | Electronic health records analyst | Running man
Joined August 2023
across the board. Given the choice, would you choose a 6-month regimen with a 93% success rate, or a 4-month regimen with a 90% success rate?.
1
0
0
This trial, led by our colleagues at @StGeorgesUni, is further evidence that short-course high-dose rifampicin regimens for pulmonary TB are safe and effective. While neither study regimen met the predefined criteria for non-inferiority, treatment success rates were high. .
Original Article: "Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis," by Amina Jindani, MD, et al. #PulmTwitter #IDTwitter #CriticalCare @DanielJGrint @StGeorgesUni @wwtb_uk @SGUL_III.
1
1
2
RT @StGeorgesUni: A higher dose and shorter treatment time of a cornerstone tuberculosis drug has proven to be safe for patients, according….
0
2
0
Delighted to finally share the results from this trial of short course high- dose rifampicin regimens for pulmonary TB! @LSHTM @ISEG_LSHTM.
Are shorter but more intensive treatment regimens for pulmonary TB effective and safe? Read the results of this non-inferiority trial by Jindani et al. comparing 4-mo high-dose rifampicin vs standard 6-mo regimen for pulmonary TB treatment. @DanielJGrint @wwtb_uk @StGeorgesUni.
0
2
3